Novo Nordisk's Wegovy pill shows promising weight loss results in new study
Novo Nordisk's oral semaglutide, similar in effectiveness to injectable Wegovy, led to significant weight loss in a 64-week study, prompting a stock surge and pending FDA approval, potentially revolutionizing obesity treatment with an oral option.
